Anti-Hu associated encephalitis: Difference between revisions
CSV import |
CSV import |
||
| Line 62: | Line 62: | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Paraneoplastic syndromes]] | [[Category:Paraneoplastic syndromes]] | ||
== Anti-Hu associated encephalitis == | |||
<gallery> | |||
File:The_Limbic_System_and_Nearby_Structures_-_John_Taylor.jpg|The limbic system and nearby structures | |||
File:Small_cell_carcinoma_(3923396504).jpg|Small cell carcinoma | |||
</gallery> | |||
Latest revision as of 02:06, 18 February 2025
| Anti-Hu associated encephalitis | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Memory loss, seizures, confusion, personality changes |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | Autoimmune response |
| Risks | |
| Diagnosis | Clinical evaluation, detection of anti-Hu antibodies |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Immunotherapy, corticosteroids, plasmapheresis |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | N/A |
Anti-Hu associated encephalitis is a rare neurological disorder characterized by inflammation of the brain due to an autoimmune response. This condition is associated with the presence of anti-Hu antibodies, which are directed against neuronal antigens. It is often linked to paraneoplastic syndromes, particularly in patients with small cell lung cancer.
Pathophysiology
Anti-Hu associated encephalitis is an autoimmune disorder where the body's immune system mistakenly attacks its own neurons. The presence of anti-Hu antibodies is indicative of an immune response against neuronal proteins. These antibodies are often produced in response to cancer, most commonly small cell lung cancer, but can also be associated with other malignancies such as neuroblastoma.
Clinical Presentation
Patients with anti-Hu associated encephalitis typically present with a variety of neurological symptoms. These may include:
The onset of symptoms can be subacute, and they may progress rapidly if not treated.
Diagnosis
Diagnosis of anti-Hu associated encephalitis involves a combination of clinical evaluation and laboratory testing. Key diagnostic steps include:
- Detection of anti-Hu antibodies in the serum or cerebrospinal fluid (CSF)
- Magnetic resonance imaging (MRI) of the brain to identify areas of inflammation
- Electroencephalogram (EEG) to assess electrical activity in the brain
- Lumbar puncture to analyze CSF for inflammatory markers
Treatment
The primary goal of treatment is to suppress the autoimmune response and manage symptoms. Treatment options include:
- Immunotherapy with agents such as intravenous immunoglobulin (IVIG) or rituximab
- Corticosteroids to reduce inflammation
- Plasmapheresis to remove antibodies from the blood
- Treatment of the underlying cancer, if present, to reduce antibody production
Prognosis
The prognosis for patients with anti-Hu associated encephalitis varies. Early diagnosis and treatment can improve outcomes, but some patients may experience persistent neurological deficits. The presence of an underlying malignancy can also affect the overall prognosis.
Also see
WikiMD neurology
External links
- Comprehensive information from the National Institute of health.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
| Hypersensitivity and autoimmune diseases (279.5–6) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Anti-Hu associated encephalitis
-
The limbic system and nearby structures
-
Small cell carcinoma